ESG for class III obesity -- Research discussion between Dr. McGowan and Dr. Maselli

Dr. Christopher McGowan, MD and Dr. Daniel Maselli, MD of True You Weight Loss discuss the findings of their publication "Endoscopic Sleeve Gastroplasty in Class III Obesity: Efficacy, safety, and durability outcomes in 404 consecutive patients"

Lead author, Dr. Maselli, will address the key findings from this landmark study, which led to the approval for Apollo ESG in patients with a BMI between 40 and 50 kg/m2.

ESG is not just for those with a lower BMI. Find out why.

Access the article in its entirety here:
https://trueyouweightloss.com/research/endoscopic-sleeve-gastroplasty-in-class-iii-obesity-weight-loss-and-metabolic-outcomes-in-404-consecutive-patients/

#endoscopicsleevegastroplasty #ESG #weightloss #nonsurgicalweightloss #research

Видео ESG for class III obesity -- Research discussion between Dr. McGowan and Dr. Maselli канала Christopher McGowan, MD